feed,title,long_url,short_url
Benzinga,Knight Therapeutics Secures Rights To Rigel's Fostamatinib In Latin America,https://benzinga.com/news/22/05/27381629/knight-therapeutics-rigel-pharmaceuticals-ink-exclusive-license-and-supply-agreements-for-fostamatin,https://bit.ly/3Ntpceg
